Related Experiment Video
Updated: Sep 10, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Interleukin-6 is elevated in plasma in multiple sclerosis
K Frei1, S Fredrikson, A Fontana
1Section of Clinical Immunology, University Hospital, Zürich, Switzerland.
Insights
Interleukin-6 (IL-6) levels were higher in the plasma of multiple sclerosis (MS) patients compared to other conditions. This suggests a potential systemic B cell response in MS, though its significance remains unclear.
Area of Science:
- Neuroimmunology
- Cytokine Research
Background:
- Interleukin-6 (IL-6) is a cytokine crucial for B cell immunoglobulin production.
- Elevated IL-6 levels are implicated in various inflammatory and neurological conditions.
Purpose of the Study:
- To measure and compare IL-6 levels in cerebrospinal fluid (CSF) and plasma of patients with multiple sclerosis (MS), acute meningo-encephalitis (AM), and tension headache (TH).
- To investigate the relationship between IL-6 levels and disease activity in MS.
- To explore the potential role of IL-6 in the pathophysiology of MS.
Main Methods:
- Quantification of IL-6 concentrations in both CSF and plasma samples.
- Comparative analysis of IL-6 levels across patient groups (MS, AM, TH).
- Longitudinal sampling in MS patients to assess disease activity correlation.
Main Results:
- MS patients exhibited significantly higher plasma IL-6 levels compared to AM and TH patients.
- In MS, plasma IL-6 was approximately 17 times higher than CSF IL-6.
- In AM, CSF IL-6 was 20-fold higher than plasma IL-6 during the acute phase, decreasing with recovery.
- No correlation was found between IL-6 levels (plasma or CSF) and MS disease activity.
Conclusions:
- Elevated plasma IL-6 in MS patients supports the hypothesis of a systemic B cell response.
- The functional significance of increased IL-6 in MS plasma requires further investigation.
- Distinct IL-6 distribution patterns were observed between MS and AM, highlighting condition-specific cytokine involvement.
Abstract:
Levels of interleukin-6 (IL-6)--a cytokine which induces immunoglobulin production of activated B cells--were measured in cerebrospinal fluid (CSF) and plasma of patients with multiple sclerosis (MS), acute meningo-encephalitis (AM) and muscular tension headache (TH). MS patients had in repeated samples higher levels of IL-6 in plasma compared to patients with AM and TH. IL-6 concentrations in MS plasma were about 17 times higher than MS CSF, while in AM 20-fold higher levels were found in CSF compared to plasma during the acute stage. IL-6 in AM CSF decreased rapidly during clinical recovery. No correlation was found between IL-6 in MS patients' plasma or CSF and disease activity. The functional significance of elevated IL-6 concentrations in MS plasma is unknown, although the findings support the hypothesis of a systemic B cell response in MS.
More Related Videos
09:43Microfluidic Approach to Resolve Simultaneous and Sequential Cytokine Secretion of Individual Polyfunctional Cells
Published on: March 8, 2024
08:43Microinjection of Interleukin-6 into the Bloodstream of TSC Zebrafish Larvae to Study Neuropsychiatric Disorder-Like Behaviors
Published on: June 26, 2026